We also found that high FGF2 levels exhibited a trend towards a correlation with worse patient survival (both overall and cancer-specific) and in the ROC curve, FGF2 exhibited a very good specificity for distinguishing bladder cancer from the normal tissue. This evidence concerns the gene FGF2 and urinary bladder carcinoma.